ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lamisil 125 mg, Tabletten - 14 Tablette(n)
51306031 Novartis Pharma Schweiz AG
Lamisil 125 mg, Tabletten27.08.1991
Original27.08.1991
Terbinafine (D01BA02)21.12.2005
WHO-DDD 
08.06.14 Tablette(n)
08.06. 
B  
Yes 
IPCI
21.83No
    
10 %39.75
7680513060314Synthetika
1594645 
Composition
terbinafinum 125 mg ut terbinafini hydrochloridum, carboxymethylamylum natricum A corresp. natrium max. 1 mg, lactosum monohydricum 21.0 mg, cellulosum microcristallinum hypromellosum, magnesii stearas, pro compresso.
Packungsbestandteile
Tablets 
 
Active AgentDose
Terbinafine125 mg
BAG: Active AgentDose
Terbinafine125 mg
 
Inactive agentsDose
Carboxymethylamylum Natricum A 
Cellulosum Microcristallinum Hypromellosum 
Lactose Monohydrate21 mg
Magnesii Stearas 
Pro Compresso 
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home